Schedule 13G ownership disclosure

Audentes Therapeutics, Inc.

Security class unavailable · CUSIP: 05070R104

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,207,650
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-007548
Form type
SC 13G/A
Filer
5AM VENTURES III, L.P.
CIK
CIK 1456890
Filed
Feb 08, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub